血小板计数作为耐火塔卡亚苏动脉炎的潜在预测因素
Xuemei Shi1, Juan Du1, Taotao Li1
1Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, Beijing, 100029, China.
Rheumatology international
|June 22, 2023
概括
血小板数量升高可能预测耐火塔卡亚苏动脉炎 (TAK). 在耐火TAK患者中观察到较高的血小板水平 (PLT),这表明PLT是密切监测和疾病评估的潜在指标.
科学领域:
- 风湿病学和免疫学
- 血液学 血液学 血液学
- 血管炎症 血管炎症
背景情况:
- 血小板参数是各种疾病中疾病严重程度的公认标志物.
- 塔卡亚苏动脉炎 (TAK) 是一种大血管血管炎,疾病严重程度和耐火性疾病过程需要更好的预测因素.
- 确定耐火TAK的可靠生物标志物对于及时干预和改善患者结果至关重要.
研究的目的:
- 调查血小板计数 (PLT) 作为耐火塔卡亚苏动脉炎 (TAK) 的预测因子的潜力.
- 为了确定相关的风险因素,并验证TAK患者血小板计数的预测值.
主要方法:
- 追溯性研究设计,使用开发数据组 (57名患者) 和验证数据组 (92名患者).
- 在耐火与非耐火TAK患者中分析血小板水平 (PLT).
- 统计分析包括风险因素的识别,切割值的确定和生存分析 (累积发病率).
主要成果:
- 与不耐药患者 (272.0 × 109/L) 相比,耐药TAK患者的血小板数量 (305.5 × 109/L) 显著增加.
- 血小板计数截止值为296.5 × 109/L被确定为耐火TAK的预测指标 (OR 4.000,p=0.021).
- 升高的PLT与更高的比例 (55.6%) 和 1,3,5年 (HR 2.106,p=0.035) 的耐火TAK累积发病率的增加有关.
结论:
- 血小板数升高是耐火性高雅苏动脉炎的统计学显著预测因素.
- 临床医生应监测TAK患者的血小板水平,计数>296.5 × 109/L,需要更密切的疾病评估和监测.
- 血小板计数作为一个有价值的,可访问的生物标志物,用于识别TAK患者的耐药性疾病过程的高风险.
相关概念视频
01:22Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
01:18Structure and Function of Platelets
1.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
567
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
567
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38